Chloride transporters and receptor-mediated endocytosis in the renal proximal tubule

Journal of Physiology

Volumn 593, Issue 18, 2015, Pages 4151-4164

  Devuyst, Olivier ^a   Luciani, Alessandro ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CHLORIDE TRANSPORTER PROTEIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN CLC 5; UNCLASSIFIED DRUG; CHLORIDE; CHLORIDE CHANNEL;

BINDING AFFINITY; CELL DIFFERENTIATION; CELL POLARITY; CELL PROLIFERATION; CHLORIDE TRANSPORT; CLCN5 GENE; CYSTIC FIBROSIS; DENT DISEASE; DISEASE ASSOCIATION; ENDOCYTOSIS; EPITHELIUM CELL; GENE; GENE MUTATION; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LIGAND BINDING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINURIA; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; ENDOSOME; ION TRANSPORT; METABOLISM; PHYSIOLOGY;

ANIMALS; CHLORIDE CHANNELS; CHLORIDES; ENDOCYTOSIS; ENDOSOMES; EPITHELIAL CELLS; HUMANS; ION TRANSPORT; KIDNEY TUBULES, PROXIMAL;

EID: 84941600343     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270087     Document Type: Review

References (84)

1. Baines RJ & Brunskill NJ (2011). Tubular toxicity of proteinuria. Nat Rev Nephrol 7, 177-180.
2. Becker-Cohen R, Rinat C, Ben-Shalom E, Feinstein S, Ivgi H & Frishberg Y (2012). Vitamin A deficiency associated with urinary retinol binding protein wasting in Dent's disease. Pediatr Nephrol 27, 1097-1102.
3. Bonventre JV (2003). Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14 (Suppl 1), S55-S61.
4. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR & Smith AE (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834.
5. Christensen EI & Birn H (2002). Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3, 256-266.
6. Christensen EI, Devuyst O, Dom G, Nielsen R, Van der Smissen P, Verroust P, Leruth M, Guggino WB & Courtoy PJ (2003). Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA 100, 8472-8477.
7. Coudroy G, Gburek J, Kozyraki R, Madsen M, Trugnan G, Moestrup SK, Verroust PJ & Maurice M (2005). Contribution of cubilin and amnionless to processing and membrane targeting of cubilin-amnionless complex. J Am Soc Nephrol 16, 2330-2337.
8. De Angeli A, Monachello D, Ephritikhine G, Frachisse JM, Thomine S, Gambale F & Barbier-Brygoo H (2006). The nitrate/proton antiporter AtCLCa mediates nitrate accumulation in plant vacuoles. Nature 442, 939-942.
9. Devuyst O, Burrow CR, Schwiebert EM, Guggino WB & Wilson PD (1996). Developmental regulation of CFTR expression during human nephrogenesis. Am J Physiol Renal Physiol 271, F723-F735.
10. Devuyst O, Christie PT, Courtoy PJ, Beauwens R & Thakker RV (1999). Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum Mol Genet 8, 247-257.
11. Devuyst O, Knoers NV, Remuzzi G & Schaefer F (2014). Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 383, 1844-1859.
12. Devuyst O & Pirson Y (2007). Genetics of hypercalciuric stone forming diseases. Kidney Int 72, 1065-1072.
13. Devuyst O & Thakker RV (2010). Dent's disease. Orphanet J Rare Dis 5, 28.
14. Dickson LE, Wagner MC, Sandoval RM & Molitoris BA (2014). The proximal tubule and albuminuria: really! J Am Soc Nephrol 25, 443-453.
15. Dutzler R, Campbell EB, Cadene M, Chait BT & MacKinnon R (2002). X-Ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature 415, 287-294.
16. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS & Levin A (2013). Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382, 158-169.
17. Erdmann KS, Mao Y, McCrea HJ, Zoncu R, Lee S, Paradise S, Modregger J, Biemesderfer D, Toomre D & De Camilli P (2007). A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev Cell 13, 377-390.
18. Faundez V & Hartzell HC (2004). Intracellular chloride channels: determinants of function in the endosomal pathway. Sci STKE 2004, re8.
19. Feng L, Campbell EB, Hsiung Y & MacKinnon R (2010). Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle. Science 330, 635-641.
20. 12)-intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood 103, 1573-1579.
21. Gadsby DC, Vergani P & Csanády L (2006). The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440, 477-483.
22. Gailly P, Jouret F, Martin D, Debaix H, Parreira KS, Nishita T, Blanchard A, Antignac C, Willnow TE, Courtoy PJ, Scheinman SJ, Christensen EI & Devuyst O (2008). A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction. Kidney Int 74, 52-61.
23. Gekle M (2005). Renal tubule albumin transport. Annu Rev Physiol 67, 573-594.
24. Gorvin CM, Wilmer MJ, Piret SE, Harding B, van den Heuvel LP, Wrong O, Jat PS, Lippiat JD, Levtchenko EN & Thakker RV (2013). Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients. Proc Natl Acad Sci USA 110, 7014-7019.
25. Günther W, Lüchow A, Cluzeaud F, Vandewalle A & Jentsch TJ (1998). ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci USA 95, 8075-8080.
26. Günther W, Piwon N & Jentsch TJ (2003). The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. Pflugers Arch 445, 456-462.
27. Guggino WB & Stanton BA (2006). New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat Rev Mol Cell Biol 7, 426-436.
28. +-ATPase and endocytosis in rat kidney cortex. Kidney Int 53, 1713-1726.
29. Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL & Scheinman SJ (2005). Dent Disease with mutations in OCRL1. Am J Hum Genet 76, 260-267.
30. Hurtado-Lorenzo A, Skinner M, El Annan J, Futai M, Sun-Wada GH, Bourgoin S, Casanova J, Wildeman A, Bechoua S, Ausiello DA, Brown D & Marshansky V (2006). V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat Cell Biol 8, 124-136.
31. Igarashi T (2009). Fanconi syndrome. In Pediatric Nephrology, ed. Avner ED, Harmon WE, Niaudet P & Yoshikawa N, pp. 1039-1067. Springer-Verlag, Berlin and Heidelberg.
32. Iglesias J, Abernethy VE, Wang Z, Lieberthal W, Koh JS & Levine JS (1999). Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol Renal Physiol 277, F711-F722.
33. Jentsch TJ (2007). Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. J Physiol 578, 633-640.
34. Jentsch TJ (2008). CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol 43, 3-36.
35. Jouret F, Bernard A, Hermans C, Dom G, Terryn S, Leal T, Lebecque P, Cassiman JJ, Scholte BJ, de Jonge HR, Courtoy PJ & Devuyst O (2007). Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney. J Am Soc Nephrol 18, 707-718.
36. Jouret F & Devuyst O (2009). CFTR and detective endocytosis: new insights in the renal phenotype of cystic fibrosis. Pflugers Arch 457, 1227-1236.
37. Jouret F, Igarashi T, Gofflot F, Wilson PD, Karet FE, Thakker RV & Devuyst O (2004). Comparative ontogeny, processing, and segmental distribution of the renal chloride channel, ClC-5. Kidney Int 65, 198-208.
38. Kasper D, Planells-Cases R, Fuhrmann JC, Scheel O, Zeitz O, Ruether K, Schmitt A, Poët M, Steinfeld R, Schweizer M, Kornak U & Jentsch TJ (2005). Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J 24, 1079-1091.
39. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M & Tsui LC (1989). Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080.
40. Kornak U, Kasper D, Bösl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G & Jentsch TJ (2001). Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205-215.
41. Kriz W & Kaissling B (2000). Structural organization of the mammalian kidney. In: The Kidney, Physiology and Pathophysiology, ed. Seldin DW & Giebisch G, pp. 587-654. Williams & Wilkins, Philadelphia.
42. Lange PF, Wartosch L, Jentsch TJ & Fuhrmann JC (2006). ClC-7 requires Ostm1 as a β-subunit to support bone resorption and lysosomal function. Nature 440, 220-223.
43. Lima WR, Parreira KS, Devuyst O, Caplanusi A, N'kuli F, Marien B, Van Der Smissen P, Alves PM, Verroust P, Christensen EI, Terzi F, Matter K, Balda MS, Pierreux CE & Courtoy PJ (2010). ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells. J Am Soc Nephrol 21, 478-488.
44. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW & Thakker RV (1996). A common molecular basis for three inherited kidney stone diseases. Nature 379, 445-449.
45. Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI & Lopez-Hernandez FJ (2011). New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 79, 33-45.
46. Lourdel S, Grand T, Burgos J, González W, Sepúlveda FV & Teulon J (2012). ClC-5 mutations associated with Dent's disease: a major role of the dimer interface. Pflugers Arch 463, 247-256.
47. Luciani A, Villella VR, Esposito S, Brunetti-Pierri N, Medina D, Settembre C, Gavina M, Pulze L, Giardino I, Pettoello-Mantovani M, D'Apolito M, Guido S, Masliah E, Spencer B, Quaratino S, Raia V, Ballabio A & Maiuri L (2010). Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol 12, 863-875.
48. 3 target genes in ClC-5 KO mice. Kidney Int 70, 79-87.
49. Mehta ZB, Pietka G & Lowe M (2014). The cellular and physiological functions of the Lowe syndrome protein OCRL1. Traffic 15, 471-487.
50. Mohammad-Panah R, Harrison R, Dhani S, Ackerley C, Huan LJ, Wang Y & Bear CE (2003). The chloride channel ClC-4 contributes to endosomal acidification and trafficking. J Biol Chem 278, 29267-29277.
51. Morales MM, Carroll TP, Morita T, Schwiebert EM, Devuyst O, Wilson PD, Lopes AG, Stanton BA, Dietz HC, Cutting GR & Guggino WB (1996). Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol Renal Physiol 270, F1038-F1048.
52. Moreau K, Luo S & Rubinsztein DC (2010). Cytoprotective roles for autophagy. Curr Opin Cell Biol 22, 206-211.
53. Moriyama Y & Nelson N (1987). The purified ATPase from chromaffin granule membranes is an anion-dependent proton pump. J Biol Chem 262, 9175-9180.
54. +-ATPase without ultrastructural changes in kidneys of Dent's disease patients. Kidney Int 63, 1285-1295.
55. Nielsen R & Christensen EI (2010). Proteinuria and events beyond the slit. Pediatr Nephrol 25, 813-822.
56. Nielsen R, Courtoy PJ, Jacobsen C, Dom G, Lima WR, Jadot M, Willnow TE, Devuyst O & Christensen EI (2007). Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells. Proc Natl Acad Sci USA 104, 5407-5412.
57. Novarino G, Weinert S, Rickheit G & Jentsch TJ (2010). Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328, 1398-1401.
58. O'Connor TM, McGrath DS, Short C, O'Donnell MJ, Sheehy M & Bredin CP (2002). Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. J Cyst Fibros 1, 31-34.
59. - channel is functional when retained in endoplasmic reticulum of mammalian cells. J Biol Chem 270, 12347-12350.
60. Picollo A & Pusch M (2005). Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436, 420-423.
61. --channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408, 369-373.
62. + exchangers in renal proximal tubules. Pflugers Arch 458, 23-27.
63. Raggi C, Fujiwara K, Leal T, Jouret F, Devuyst O & Terryn S (2011). Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease. Pflugers Arch 462, 851-860.
64. Raggi C, Luciani A, Nevo N, Antignac C, Terryn S & Devuyst O (2014). Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis. Hum Mol Genet 23, 2266-2278.
65. Reed AA, Loh NY, Terryn S, Lippiat JD, Partridge C, Galvanovskis J, Williams SE, Jouret F, Wu FT, Courtoy PJ, Nesbit MA, Rorsman P, Devuyst O, Ashcroft FM & Thakker RV (2010). CLC-5 and KIF3B interact to facilitate CLC-5 plasma membrane expression, endocytosis, and microtubular transport: relevance to pathophysiology of Dent's disease. Am J Physiol Renal Physiol 298, F365-F380.
66. Rickheit G, Wartosch L, Schaffer S, Stobrawa SM, Novarino G, Weinert S & Jentsch TJ (2010). Role of ClC-5 in renal endocytosis is unique among ClC exchangers and does not require PY-motif-dependent ubiquitylation. J Biol Chem 285: 17595-17603.
67. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS & Tsui LC (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073.
68. Rowe SM, Miller S & Sorscher EJ (2005). Cystic fibrosis. N Eng J Med 352, 1992-2001.
69. Scheel O, Zdebik AA, Lourdel S & Jentsch TJ (2005). Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature 436, 424-427.
70. Scheinman SJ (1998). X-Linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 53, 3-17.
71. Sheppard DN & Welsh MJ (1999). Structure and function of the CFTR chloride channel. Physiol Rev 79, S23-S45.
72. Shrimpton AE, Hoopes RR Jr, Knohl SJ, Hueber P, Reed AAC, Christie PT, Igarashi T, Lee P, Lehman A, White C, Milford DV, Sanchez MR, Unwin R, Wrong OM, Thakker RV & Scheinman SJ (2009). OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiol 112, p27-p36.
73. Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB & Guggino SE (2003). The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res 18, 615-623.
74. Stauber T & Jentsch TJ (2013). Chloride in vesicular trafficking and function. Annu Rev Physiol 75, 453-477.
75. Suzuki T, Rai T, Hayama A, Sohara E, Suda S, Itoh T, Sasaki S & Uchida S (2006). Intracellular localization of ClC chloride channels and their ability to form hetero-oligomers. J Cell Physiol 206, 792-798.
76. Tanaka K, Terryn S, Geffers L, Garbay S, Pontoglio M & Devuyst O (2010). The transcription factor HNF1α regulates expression of chloride-proton exchanger ClC-5 in the renal proximal tubule. Am J Physiol Renal Physiol 299, F1339-F1347.
77. Terryn S, Jouret F, Vandenabeele F, Smolders I, Moreels M, Devuyst O, Steels P & Van Kerkhove E (2007). A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. Am J Physiol Renal Physiol 293, F476-F485.
78. Villella VR, Esposito S, Bruscia EM, Vicinanza M, Cenci S, Guido S, Pettoello-Mantovani M, Carnuccio R, De Matteis MA, Luini A, Maiuri MC, Raia V, Kroemer G & Maiuri L (2013). Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator. Cell Death Differ 20, 1101-1115.
79. Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S & Guggino WB (2000). Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9, 2937-2945.
80. - accumulation. Science 328, 1401-1403.
81. Wu F, Reed AAC, Williams SE, Loh NY, Lippiat JD, Christie PT, Large O, Bettinelli A, Dillon MJ, Goldraich NP, Hoppe B, Lhotta K, Loirat C, Malik R, Morel D, Kotanko P, Roussel B, Rubinger D, Schrander-Stumpel C, Serdaroglu E, Nesbit MA, Ashcroft F & Thakker RV (2009). Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease. Nephron Physiol 112, 53-62.
82. Wu F, Roche P, Christie PT, Loh NY, Reed AAC, Esnouf RM & Thakker RV (2003). Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney Int 63, 1426-1432.
83. 2 activates G protein, α 12 to disrupt the junctional complex and enhance ischemia reperfusion injury. Proc Natl Acad Sci USA 109, 6680-6685.
84. Zhang X, Hartz PA, Philip E, Racusen LC & Majerus PW (1998). Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4, 5-bisphosphate. J Biol Chem 273, 1574-1582.